Clinical Trials Logo

Type 2 Diabetes clinical trials

View clinical trials related to Type 2 Diabetes.

Filter by:

NCT ID: NCT00390637 Completed - Obesity Clinical Trials

Diet, Obesity and Genes (DiOGenes)

DIOGENES
Start date: January 2006
Phase: Phase 4
Study type: Interventional

Study Title: Diogenes, A randomised controlled trial comparing the effect of reduced-fat diets varying in glycaemic index (high vs. low) and protein content (high vs. normal) on bodyweight in overweight and obese subjects after an initial weight loss.

NCT ID: NCT00388050 Completed - Type 2 Diabetes Clinical Trials

Diabetes Medication Choice

Start date: July 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to examine how different ways of sharing information about diabetes medication treatment options with patients can affect their choices and health.

NCT ID: NCT00381186 Completed - Type 2 Diabetes Clinical Trials

Impact of 3-year Lifestyle Intervention on Postprandial Glucose Metabolism: the SLIM Study

Start date: February 1999
Phase: N/A
Study type: Interventional

To evaluate the effect of a 3-year diet- and exercise lifestyle intervention, based on general public health recommendations, on glucose tolerance, insulin resistance and metabolic cardiovascular risk factors in Dutch subjects with impaired glucose tolerance (IGT).

NCT ID: NCT00374907 Completed - Type 2 Diabetes Clinical Trials

A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Start date: September 2006
Phase: Phase 3
Study type: Interventional

The purpose of this clinical research study is to learn whether Saxagliptin can improve the body's ability to make its own insulin and lower blood sugar in people with type 2 diabetes

NCT ID: NCT00372463 Completed - Type 2 Diabetes Clinical Trials

Internet Diabetes Self-Management

Start date: February 2006
Phase: Phase 2
Study type: Interventional

Diabetes is a growing health problem causing personal suffering, comorbid conditions, premature death, and high costs to the individual, the health care system and society. Many of these problems can be prevented or delayed by controlling the disease. This in turn requires daily self-management by patients. We will evaluate an Internet based small group Diabetes Self-Management Program. This program will be adapted from the Chronic Disease Self-Management Program Online, already developed and currently being evaluated by the investigators. Participants with type 2 diabetes will be randomized to participate in the Internet Program or serve as controls continuing with usual care. Treatment subjects will participate in a structured 6 week interactive web-based online class with 20-24 other participants and 2 trained peer moderators. If successful, this project will result in a new and effective means of reaching the CDC objective and more importantly in improving the quality of life and health status of people with diabetes while reducing health care utilization and thus costs.

NCT ID: NCT00364988 Completed - Type 2 Diabetes Clinical Trials

Pioglitazone and Losartan Provides Additional Renoprotection

Start date: January 2005
Phase: N/A
Study type: Interventional

Peroxisomal proliferator-activated receptor agonist pioglitazone and rosiglitazone are currently used in the treatment of type 2 diabetes, as efficient insulin sensitizers alone or in combination with insulin.angiotensin II receptor antagonist losartan reduced the levels of proteinuria.Whether Combination therapy with pioglitazone and losartan provides additional renoprotection in subjects with type 2 diabetic nephropathy,it's worth researching.

NCT ID: NCT00363233 Completed - Type 2 Diabetes Clinical Trials

The Potential Effects and Mechanisms of Flax Lignans on Type 2 Diabetes Mellitus

Start date: March 2006
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of the study is to improving the lipid profile and glucose control in type 2 diabetic patients with supplementation of flax lignans. We hypothesize that flax lignans supplement will improve the cholesterol profile and glucose control in type 2 diabetic patients.

NCT ID: NCT00362193 Completed - Type 2 Diabetes Clinical Trials

Glycemic Relapse Prevention: Maintenance Dose Assessment

Start date: June 2002
Phase: Phase 4
Study type: Interventional

This purpose of this study is to determine the optimal frequency of maintenance intervention needed to prevent glycemic relapse.

NCT ID: NCT00362011 Completed - Type 2 Diabetes Clinical Trials

Effect of Chia Seeds (Salvia Hispanica L.) on Glucose Control in Patients With Type 2 Diabetes

Start date: March 2001
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether the addition of Salvia hispanica L. Alba (Salba) to the conventional treatment for diabetes is associated with improvement in major and emerging cardiovascular risk factors in people with type 2 diabetes.

NCT ID: NCT00361946 Completed - Type 2 Diabetes Clinical Trials

The Role of Amylin and Incretins on Postprandial Metabolisms in Adolescents With Type 2 Diabetes Mellitus (T2DM).

Start date: August 2006
Phase: N/A
Study type: Observational

To study postprandial metabolism in lean, obese and T2DM adolescents using a mixed meal challenge. Specifically we will be measuring the following parameters of postprandial metabolism: 1. Postprandial glucose and triglycerides excursions 2. Gastric emptying 3. Insulin, amylin, glucagon, GLP-1 and ghrelin secretion 4. Glucose Turnover rate